This finding aligns with previous research demonstrating that FGFBP1 knockdown exerts tumor-inhibiting effects in colon carcinoma, including anti-proliferative and pro-apoptotic effects leading to cell cycle arrest (Schulze et al., 2011). The gene discussed is FGFBP1; the disease is neoplasm.